Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 15, 2007
app pub date -
Nov 7, 2003
filing date -
Nov 8, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A composition, method and kit comprising a compound for the inhibition of the binding of .alpha..sub.4.beta..sub.1 integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin and other therapeutic compounds for the control or prevention of diseases states in which .alpha..sub.4.beta..sub.1 is involved.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully